Evidence-Based Complementary and Alternative Medicine

Natural Product Acting as Epigenetic Modulating Agents


Publishing date
01 Sep 2022
Status
Published
Submission deadline
29 Apr 2022

Lead Editor

1Case Western Reserve University, Cleveland, USA

2Nanjing University of Chinese Medicine, Nanjing, China

3Nankai University, Tianjin, China


Natural Product Acting as Epigenetic Modulating Agents

Description

In every cell, some specific genes are activated and some genes are suppressed, forming multiple gene expression patterns. In the process of epigenetic regulation, DNA sequence does not change, but gene expression can be genetically altered. Epigenetic changes include DNA methylation, histone modification and noncoding RNA action, genomic imprinting, maternal influence, gene silencing, nucleolar dominance, dormant transposon activation, etc. Fundamentally, epigenetic phenomena are the result of changes in genetic material in living cells caused by environmental factors. Epigenetic changes are caused by interactions between environmental factors and intracellular genetic material. The effect is achieved by regulating gene expression and controlling biological phenotypes. It is precisely because of the importance of epigenetic modifications in maintaining the internal environment and function of various organ systems that epigenetic abnormalities cause disease. This has become the focus of drug and treatment design.

Unlike diseases caused by changes in DNA sequences, many epigenetic changes are reversible. By means of epigenetic modulators, we can change the epigenetic inheritance of abnormal cells to achieve the purpose of treating diseases. Natural products have documented large structural diversity with unique and complex scaffolds with promising activity and selectivity profile for epigenetic targets. Traditional Chinese medicine can be used as an epigenetic regulator to achieve anti-inflammatory, antioxidant, tumor metastasis and recurrence prevention, improve tumor quality of life, and prolong survival time. Microorganisms can also regulate the physiological functions of the host during infection, and epigenetic regulation is an important regulation mode. Epigenetic regulation plays an important role in the host immune responses induced by microorganisms. Clarifying the mechanism of microbial epigenetic regulation on the host is conducive to the development of clinical targeted therapies, strengthening the clinical application of epigenetic modulators, and providing new strategies for the prevention and treatment of related diseases. Strong antioxidants such as polyphenols in fruits, green tea, curcumin, and soy isoflavones can obtain anticancer activity by regulating the patient's epigenome, thereby inhibiting proto-oncogenes or activating tumor suppressors.

This Special Issue welcomes original research and reviews which focus on this topic.

Potential topics include but are not limited to the following:

  • Traditional Chinese medicines as epigenetic modulating agents
  • Microorganisms and their metabolites as epigenetic modulating agents
  • Regulation of epigenetic regulation by animal or plant-derived components
  • Implications of compounds of natural origin in disease-associated epigenetic mechanisms
  • Epigenetics and network pharmacology associated with treatment with natural remedies
  • Repurposing of natural products with epigenetic functions through an integrated –omics analysis

Articles

  • Special Issue
  • - Volume 2023
  • - Article ID 9854736
  • - Retraction

Retracted: Correlation between Platelet miRNA Expression and Coagulation Function in Children with Severe Pneumonia

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9850872
  • - Retraction

Retracted: Minocycline plus Zinc Oxide Eugenol Cement Might Be A Promising Alternative for Acute Pulpitis

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9820171
  • - Retraction

Retracted: Effect of miR-488 on Colon Cancer Biology and Clinical Applications

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9754249
  • - Retraction

Retracted: Correlation between Drug Resistance of Klebsiella Pneumonia and Antimicrobial Drug Usage

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9787205
  • - Retraction

Retracted: Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9763418
  • - Retraction

Retracted: Effectiveness of Proanthocyanidin plus Trimetazidine in the Treatment of Non-Small-Cell Lung Cancer with Radiation Heart Injury

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9785474
  • - Retraction

Retracted: Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9804916
  • - Retraction

Retracted: Value of MSCT plus MRI in the Detection of Colon Cancer

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9843460
  • - Retraction

Retracted: The Efficacy of Minocycline Hydrochloride Combined with Multiple Antibiotic Paste in Elderly Patients with Chronic Periodontitis and Concomitant Pulp Lesions

Evidence-Based Complementary and Alternative Medicine
  • Special Issue
  • - Volume 2023
  • - Article ID 9898404
  • - Retraction

Retracted: Efficacy of Methylprednisolone plus Azithromycin in the Treatment of RMPP and Its Effect on the Changes of T Lymphocyte Subsets

Evidence-Based Complementary and Alternative Medicine
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.